je.st
news
Tag: phase
Vermont Gas dismisses phase two of pipeline project
2015-02-10 21:14:40| Paper - Topix.net
Vermont Gas says it will not proceed with phase two of its pipeline expansion project that would have carried natural gas from Middlebury to International Paper in Ticonderoga, N.Y. In a media release, Don Rendall, president and CEO of the company, cited a cost increase in the project and differences with IP. A review of the project, conducted by Vermont Gas at the request of the Public Service Board, found the cost of phase two would increase from $74.4 million to $105 million.
Tags: project
gas
phase
vermont
GSK and Theravance Announce Start of Phase III Lung Function Study...
2015-02-10 06:04:15| Biotech - Topix.net
Enrolling approximately 1,800 patients, the FULFIL study will assess whether the inhaled corticosteroid, long-acting muscarinic antagonist and long-acting beta2-adrenergic agonist combination, all delivered in GSK's ElliptaA inhaler, can improve lung function and health-related quality of life compared with budesonide/formoterol, a twice-daily ICS/LABA combination delivered via the TurbohalerA dry powder inhaler. Secondary objectives include investigating the effect on the rate of exacerbations with FF/UMEC/VI compared with budesonide/formoterol, and the safety profile of FF/UMEC/VI compared with budesonide/formoterol.
Tags: start
study
iii
function
Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
2015-02-09 18:35:24| Biotech - Topix.net
Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced enrollment of the 700th patient in the NeuVax Phase 3 PRESENT clinical trial. NeuVax is a first-in-class, HER2-directed cancer immunotherapy under evaluation to prevent breast cancer recurrence after standard of care treatment in the adjuvant setting.
Tags: present
trial
phase
patient
Custom MMIC Awarded U.S. Navy Phase II SBIR Contract
2015-02-06 06:23:09| rfglobalnet Home Page
Custom MMIC, a developer of performance-driven monolithic microwave integrated circuits (MMICs), is pleased to announce the awarding of a Phase II Small Business Innovative Research (SBIR) contract from the United States Navy, entitled “Gallium Nitride Based Activity Electronically Scanned Array (AESA) Technology for High Altitude Periscope Detection.”
Tags: custom
contract
phase
awarded
Enanta Announces 95 percent SVR12 Rate In AbbVie's Phase 3 Study Of All-Oral Treatment For Hepatitis C Virus In Japanese Patients
2015-02-04 07:01:33| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, recently announced topline Phase 3 results from the GIFT-1 study, AbbVie’s investigational, all-oral, ribavirin-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir (OBT/PTV/r) in patients with genotype 1b (GT1b) chronic hepatitis C virus (HCV) infection in Japan
Sites : [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] next »